MSI-H Biomarker | Colorectal Cancer Alliance
Cancers | Free Full-Text | Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
Understanding MSI-High and DNA Mismatch Repair - CancerConnect
Final Results Support Pembrolizumab as Standard of Care in MSI-H/dMMR Metastatic Colorectal Cancer - Cancer Therapy Advisor
In patients with dMMR or MSI-H-positive tumors, multiple mutations... | Download Scientific Diagram
Study design Patients with dMMR or pMMR colon cancers were screened... | Download Scientific Diagram
Cancers | Free Full-Text | Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High Gastrointestinal Cancers: A Changing Paradigm
Current Oncology | Free Full-Text | Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer
Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology
ESMO | Press Release | preoperative immunotherapy colon cancer
Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside. - Abstract - Europe PMC
Molecular strategy to distinguish LS-related from sporadic MSI/dMMR... | Download Scientific Diagram
Purpose
Advances in immune therapies for the treatment of microsatellite instability‑high/deficient mismatch repair metastatic colorectal cancer (Review)
Therapy with pembrolizumab in treatment‐naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer - Eefsen - 2023 - International Journal of Cancer - Wiley Online Library
Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer | Scientific Reports
Immunotherapy in colorectal cancer: current achievements and future perspective
ESMO22 Highlights on neoadjuvant ICI in locally advanced dMMR colon cancer: The NICHE-2 study - YouTube
An example of early-stage dMMR type 2 colorectal cancer stained with... | Download Scientific Diagram
New Standard of Care for Early dMMR/MSI-H Colorectal Cancer?
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms | British Journal of Cancer
Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside - ScienceDirect
Immunotherapy Combination Approved for Colorectal Cancer - NCI
